Markets

Dr. Reddy's Laboratories Q2 Profit Rises

October 25, 2025 — 12:21 am EDT

Written by RTTNews.com for RTTNews

(RTTNews) - Dr. Reddy's Laboratories Ltd. (ROY) reported, under IFRS standards, that its second quarter profit attributable to equity holders of the parent company increased to INR 14.37 billion or INR 17.25 per share from INR 12.55 billion or INR 15.05 per share in the prior year.

Revenues for the quarter grew to INR 88.05 billion from INR 80.162 billion last year, driven by broad-based growth across key markets. However, the North America Generics segment faced headwinds due to heightened price erosion in select products and reduced lenalidomide sales. The recently acquired Consumer Healthcare portfolio in Nicotine Replacement Therapy (NRT) also contributed positively to overall performance.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source

Tags

Markets
Stocks Mentioned
RDY

Latest Articles
Data is currently not available